Fosaprepitant for Breakthrough Chemotherapy Induced Nausea and Vomiting

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
OHSU Knight Cancer Institute
ClinicalTrials.gov Identifier:
NCT00939302
First received: July 13, 2009
Last updated: April 30, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)